Blog
DEA Chronicles
By Cote Law PLLC Visit the blog
143 published works
DEA Chronicles
Criminal Investigation Against Drug Distributor Resolved with Deferred Prosecution Agreement
On January 13, 2026, the United States Department of Justice (DOJ) announced that Atlantic Biologicals Corporation, a Miami-based pharmaceutical distributor, paid a $450,000 criminal penalty and entered into a two-year…
DEA Chronicles
Don’t Be the Headline: How to Avoid a Compliance Crisis
“Breaking news: Controlled substance compliance failures rock major corporation.” This is the kind of headline that doesn’t just attract attention. It plants doubt in your whole organization. https://youtu.be/g1LnpjvcdFQ?feature=shared Imagine this:…
DEA Chronicles
Losing Your DEA Registration – No Actual Diversion Required
I know it can be said about many areas of the law; however, the statue, regulations, and administrative caselaw governing controlled substances is truly a different animal. I frequently get…
DEA Chronicles
Introducing ARCOS IQ
I am extremely excited to announce the latest addition to the Controlled Substance Solutions (CSS) software suite - ARCOS IQ. So, what is ARCOS IQ? I am glad you asked. …
DEA Chronicles
I Always Feel Like Somebody’s Watching Me
(If this song is stuck in your head all day long, you are welcome.) As my loyal readers are aware (too Bridgerton?), customer due diligence obligations, especially for distributors and…
DEA Chronicles
Ignore Red Flags at Your Own Peril
Today, the Drug Enforcement Administration announced the revocation of Coconut Grove Pharmacy’s DEA registration. DEA issued an Order to Show Cause and Immediate Suspension of Registration back in September 2022,…
DEA Chronicles
A Distributor’s Conundrum: When DEA and state law collide
In a highly regulated industry, such as controlled substance distribution, having clarity of regulatory requirements facilitates implementation and execution of an effective compliance program. Uncertainty on expectations from regulators and/or…
DEA Chronicles
Congress Seeks to Provide Clarity on Suspicious Order Monitoring
There is legislation making the rounds on Capitol Hill that seeks to provide clarity regarding the process for reviewing orders for controlled substances to determine if an order is a…
DEA Chronicles
DEA Issues New/Old Guidance on Suspicious Order Monitoring
On January 20, 2023, the Drug Enforcement Administration (DEA’s) issued a Guidance Document reiterating DEA’s long-held position regarding the detection and reporting of suspicious orders. Specifically, DEA "clarified" that “neither the…
DEA Chronicles
New Software Platform for Controlled Substance Compliance
Happy New Year everyone! I wanted to share with you some news about a project I have been working on that I believe can be a game-changer for your controlled…